OM1 this week announced it had raised a new round of financing to $21 million to continue to deliver robust solutions in real-world evidence, big data and health care technology.
According to a press release, the most recent round of financing was led by Polaris Partners alongside existing investors, including General Catalyst and 7wire Ventures.
In addition to the funding, OM1 announced Dave Barrett, Polaris Partners managing partner, has joined the OM1 Board of Directors.
“Applying advanced technologies to make treatment outcomes data actionable is game changing,” Barrett said in a statement. “OM1 is driving a new paradigm that promises better decision-making for healthcare and life sciences organizations.”
Dr. Richard Gliklich, OM1 founder and CEO, says the new funding will allow OM1 to double down on tech optimization and development.
“Healthcare stakeholders are moving rapidly towards recognizing that clinical outcomes are the most important metric in healthcare,” Gliklich said in a statement. “With this funding, OM1 can accelerate the technologies that are making those outcomes accessible, and useful across a spectrum of needs for real-world evidence and value-based care.”